Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0TD2G
|
|||
| Former ID |
DCL000735
|
|||
| Drug Name |
Canakinumab
|
|||
| Synonyms |
Ilaris (TN)
Click to Show/Hide
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Cryopyrin-associated periodic syndromes [ICD-11: 4A60.1; ICD-10: D89.8] | Approved | [1], [2] | |
| Rheumatoid arthritis [ICD-11: FA20] | Approved | [1], [2] | ||
| Urticaria [ICD-11: EB00-EB05] | Phase 2 | [1], [2] | ||
| Vasculitis [ICD-11: 4A44] | Phase 2 | [1], [2] | ||
| Company |
Novartis
|
|||
| ADReCS Drug ID | BADD_D00345 | |||
| SuperDrug ATC ID |
L04AC08
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6773). | |||
| REF 2 | Hughes B: 2009 FDA drug approvals. Nat Rev Drug Discov. 2010 Feb;9(2):89-92. | |||
| REF 3 | Emerging drugs for rheumatoid arthritis. Expert Opin Emerg Drugs. 2008 Mar;13(1):175-96. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.